NEW YORK (dpa-AFX Broker) - The US investment bank Goldman Sachs has given Carl Zeiss Meditec a "Neutral" rating and a price target of 110 euros. The medium-term growth prospects for the technology group are robust, wrote analyst Richard Felton in a study published on Wednesday. However, this has already been taken into account in the consensus estimates and the valuation. In the short term, the market environment is rather "mixed", which could slow down growth, as parts of Carl Zeiss Meditec's business are more cyclical than usual in medical technology./bek/la

Publication of the original study: 10.04.2024 / 05:06 / BST

First disclosure of the original study: Date not specified in study / Time not specified in study / Time zone not specified in study

-----------------------

dpa-AFX Broker - the Trader News from dpa-AFX

-----------------------